Skip to main content
Quest Diagnostics

Molecular Testing for Birt-Hogg-Dube Syndrome in Patients With Isolated Pulmonary Findings: A Commercial Laboratory’s Experience

CHEST 2024

Annual Meeting American College of Chest Physicians

ston, MA, Oct 6-9, 2024

Poster presentation: Molecular Testing for Birt-Hogg-Dube Syndrome in Patients With Isolated Pulmonary Findings: A Commercial Laboratory’s Experience

Authors: Nordquist EN, Tully DM

Specialty: Oncology, Genetics

Related content

Audio Podcast
Insights into successful family planning: A diagnostics perspective
By: Dr. Damian P. "Pat" Alagia III, MD, MS, MBA, FACS, FACOG
Audio Podcast
The power of laboratory analytics
Conference Presentation
Genetic Findings in a Cohort of Patients with Pulmonary Arterial Hypertension Referred for NGS Panel Testing
Conference Presentation
Diagnostic Yield of Genetic Testing in an Unselected Cohort of Patients with Congenital Heart Disease

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.